About Jeffrey Hubbell
Form D filings for SNC Therapeutics in 2023 list Jeffrey Hubbell as executive officer.
Jeffrey Hubbell first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Hubbell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Hubbell works with at each company, as listed on that company's latest Form D.
SNC Therapeutics, Inc. · Form D, Mar 8, 2023
MC
Margarita Chavez
Director
ES
Evan Scott
Chief Executive Officer and director